Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novartis Pharmaceuticals
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who have successfully completed protocol No. CLCZ696A2219 and who, as judged by the study investigator, are able to continue in the current study.
Ability to communicate and comply with all study requirements and demonstrate good medication compliance during CLCZ696A2219.
You may not be if
Patients who did not complete CLCZ696A2219.
Presence of significant protocol violation in CLCZ696A2219.
Patients who are deemed to be unable to comply with the protocol by the investigator.
